Advertisement

Proto-Oncogene Expression and Proliferative Activity in Human Malignant Gliomas

  • Alberto Riccardi
  • Marco Danova
  • Monica Giordano
  • Paolo Gaetani
  • Giorgio Butti
  • Carlo Zibera
  • Giuliano Mazzini
Chapter
Part of the Developments in Oncology book series (DION, volume 66)

Abstract

The identification of oncogene products that are highly expressed in malignant glial cells could permit its use both in the diagnosis and in the grading of malignant brain tumors. In this study monoclonal antibodies to the Ha-ras and c-myc gene products (i.e. p21 and p62 oncoprotein respectively) were used in conjunction with flow cytometry (FCM) to characterize and quantitate the oncoprotein expression in 2 human glioblastoma-derived primary cell lines, 5 fresh malignant gliomas and 2 nonneoplastic brain tisue biopsy sample. In these experiments, the levels of the p21 and p62 fluorescence (i.e. Ha-ras and c-myc oncogene expression) in the malignant cultured cells and in the brain tumors samples were more than three times that of the nonneoplastic cells. FCM was also used to relate the quantity of the Ha-ras and c-myc oncoproteins present in the cells to their cell cycle phase. In all neoplastic specimens (which showed diploid DNA content), there was an equal distribution of p21 in G0/ G1, S and G2-M phases of the cell cycle while, the p62 underwent a twofold increase as the cells progresed from G0/G1 to G2-M. The results support the hypotesis of Haras and c-myc activation in human glioblastomas, also, FCM permits a simultaneous examination of the cytokinetic characteristics of tumor cells and oncogene expression, providing a useful tool in the study of molecular biology of brain tumors.

Keywords

Malignant Glioma Human Glioblastoma Cell Line Oncogene Product Cellular Oncogene Oncoprotein Expression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1).
    Gerosa M, Talarico D, Fognani C, Raimondi E, Colombatti M, Tridente G, DeCarli L, Della Valle G, Colombatti M (1989)’ Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas’, J Natl Cancer Inst 81, 63–67.PubMedCrossRefGoogle Scholar
  2. 3).
    Blin N, Muller-Brechlin R, Carstens C, Meese E, Zang KD (1987)’ Enhanced expression of four cellular oncogenes in a human glioblastoma cell line’, Cancer Genet Cytogenet 25, 285–292.PubMedCrossRefGoogle Scholar
  3. 4).
    Stewart CC (1989)’ How cytometric analysis of oncogene expression in human neoplasias’. Arch Pathol Lab Med, 113, 634.PubMedGoogle Scholar
  4. 5).
    Danova M, Riccardi A, Giordano M (1988)’ Cell cycle-related proteins: a flow cytofluorometric study in human tumors’, Biol Cell, 64, 23.PubMedCrossRefGoogle Scholar
  5. 6).
    Giordano M, Danova M, Riccardi A, Mazzini G (1989)’ Simultaneous detection of cellular ras p21 oncogene product and DNA content by two parameter flow cytometry. Anticancer Res, 9, 799.PubMedGoogle Scholar
  6. 7).
    Danova M, Riccardi A, Mazzini G (1990)’ Cell cycle-related proteins and flow cytometry’, Haematologica 75, 252.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1991

Authors and Affiliations

  • Alberto Riccardi
    • 1
  • Marco Danova
    • 1
  • Monica Giordano
    • 1
  • Paolo Gaetani
    • 1
    • 2
  • Giorgio Butti
    • 1
    • 2
  • Carlo Zibera
    • 1
    • 3
  • Giuliano Mazzini
    • 1
    • 4
  1. 1.Department of Internal Medicine2nd Medical ClinicItaly
  2. 2.Department of SurgeryNeurosurgical Section University and I.R.C.C.S. Policlinico San MatteoItaly
  3. 3.Foundation Clinica del LavoroPaviaItaly
  4. 4.Centro Studio Istochimica C.N.RItaly

Personalised recommendations